Učitavanje...
A retrospective study evaluating the efficacy and safety of bendamustine in the treatment of mantle cell lymphoma
Bendamustine is approved in the United States for relapsed indolent lymphoma. However, it has not been widely studied in mantle cell lymphoma (MCL). We retrospectively reviewed the records of all patients with MCL who were treated with bendamustine at three centers. The primary endpoint was overall...
Spremljeno u:
| Izdano u: | Leuk Lymphoma |
|---|---|
| Glavni autori: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
2012
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4570573/ https://ncbi.nlm.nih.gov/pubmed/22185662 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/10428194.2011.649476 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|